This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
Millions of adults are diagnosed as obese each year worldwide Many of these people suffer from a disorder known as metabolic syndrome which includes symptoms such as hypertension and elevated blood cholesterol They are also at risk of developing additional diseases such as heart disease and diabetes mellitus Obesity may in fact be a major cause of...
Leading pharma or biotech executives often hold degrees in science including medicine or in business For scientists who are interested in pursuing careers in management one hurdle is to acquire the knowledge and skills necessary to excel in a business environment and for executives with a business education it can at times be challenging to underst...
Financial performance of large innovative pharmaceutical companies in indicated a gloomy prospect for these wellestablished leaders in their domain This trend is expected to grow as many drugs are going offpatent in time to come and with very few blockbusters drugs entering to market due to strict FDA regulations For instance Pfizer stands to lose...
Millions of adults are diagnosed as obese each year worldwide Many of these people suffer from a disorder known as metabolic syndrome which includes symptoms such as hypertension and elevated blood cholesterol They are also at risk of developing additional diseases such as heart disease and diabetes mellitus Obesity may in fact be a major cause of...
Leading pharma or biotech executives often hold degrees in science including medicine or in business For scientists who are interested in pursuing careers in management one hurdle is to acquire the knowledge and skills necessary to excel in a business environment and for exe
Financial performance of large innovative pharmaceutical companies in indicated a gloomy prospect for these wellestablished leaders in their domain This trend is expected to grow as many drugs are going offpatent in time to come
Despite progress on several preventive and therapeutic fronts cancer remains one of the major causes of morbidity and mortality worldwide According to the estimates about million new cases of cancer will be diagnosed and approximately deaths will occur due to cancer in the United
Since layerbylayer LbL polyelectrolyte assembly was introduced in the s by G Decher Y Lvov H Mhwald and M Rubner it has found application in various fields that study and apply nanotechnology LbL nanoassembly is based on the sequential adsorption of positively and negatively charged polymers on a surface to form a nanothick film of coating The proc...
Despite progress on several preventive and therapeutic fronts cancer remains one of the major causes of morbidity and mortality worldwide According to the estimates about million new cases of cancer will be diagnosed and approximately deaths will occur due to cancer in the United
Since layerbylayer LbL polyelectrolyte assembly was introduced in the s by G Decher Y Lvov H Mhwald and M Rubner it has found application in various fields that study and apply nanotechnology LbL nanoassembly is based on the sequential adsorption of positively and negatively charged polymers on a surface to form a nanothick film of coating The proc...
Clinical trials and Medical research is experiencing the fastest transition that it ever experienced With continuous innovation in technology drug research initiatives are getting tremendous support in terms of getting more compliant and secure processes in place making the research more result oriented With a fact that the cost to develop a drug a...
Clinical trials and Medical research is experiencing the fastest transition that it ever experienced With continuous innovation in technology drug research initiatives are getting tremendous support in terms of getting more compliant and secure processes in place making the research more result oriented With a fact that the cost to develop a drug a...
In the past three decades biotechnologyled medicines have revolutionised the treatment of several life threatening and rare diseases The substances produced by living cells and used in the treatment diagnosis or prevention of diseases are referred to as biologic drugs or biologics or biopharmaceuticals or recombinant therapeutics Since the approval...
Biosimilars also known as followon biologics or similar biological medicinal product henceforth referred to as biosimilars are products that are similar to but not the same as an innovators drug Since they are expected to cost less than an innovators drug they bring affordable alternatives for treatment for patients who previously could not affo
In the past three decades biotechnologyled medicines have revolutionised the treatment of several life threatening and rare diseases The substances produced by living cells and used in the treatment diagnosis or prevention of diseases are referred to as biologic drugs or biologics or biopharmaceuticals or recombinant therapeutics Since the approval...
Biosimilars also known as followon biologics or similar biological medicinal product henceforth referred to as biosimilars are products that are similar to but not the same as an innovators drug Since they are expected to cost less than an innovators drug they bring affordable alternatives for treatment for patients who previously could not afford...
Functional service has been ranked high among the buzz words of the clinical research industry Both sponsor organisations and service providers are equally excited about the opportunities this model offers and the potentially winwin situation it provides to them Sponsor organisations typically send individual protocolrelated service RFPs request fo...
Functional service has been ranked high among the buzz words of the clinical research industry Both sponsor organisations and service providers are equally excited about the opportunities this model offers and the potentially winwin situation it provides to them Sponsor organisations typically send individual protocolrelated service RFPs request fo...
